Afzal, M., Sah, A. K., Agarwal, S., Tanzeel, A., Elshaikh, R. H., Alobeidli, F. A., et al. (2024). Advancements in the treatment of autoimmune diseases: Integrating artificial intelligence for personalized medicine. Trends in Immunotherapy, 8(2), 8970.
Alam, M. T., Amos, G. C., Murphy, A. R., Murch, S., Wellington, E. M., & Arasaradnam, R. P. (2020). Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut Pathogens, 12, 1–8.
Article CAS PubMed PubMed Central Google Scholar
Armstrong, D., Dregan, A., Ashworth, M., White, P., McGee, C., & de Lusignan, S. (2020). Influence of prior antibiotic use on risk of rheumatoid arthritis: Case control study in general practice. Rheumatology, 59(6), 1281–1287.
Arriaga-Morales, J. J., Ordaz-Pichardo, C., Castro-Muñoz, R., & Durán-Páramo, E. (2023). Attenuation of hyperglycemia in diabetic rats assisted by immobilized probiotic in sodium alginate. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-023-10166-3
Article PubMed PubMed Central Google Scholar
Avci, F. Y., & Kasper, D. L. (2009). How bacterial carbohydrates influence the adaptive immune system. Annual Review of Immunology, 28(1), 107–130.
Azzouz, D. F., Chen, Z., Izmirly, P. M., Chen, L. A., Li, Z., Zhang, C., et al. (2023). Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares. Annals of the Rheumatic Diseases, 82(10), 1315–1327.
Article CAS PubMed Google Scholar
Bamias, G., Rivera-Nieves, J., & Grisham, M. B. (2018). Recruitment of Inflammatory and Immune Cells in the Gut. Physiology of the gastrointestinal tract (pp. 1579–1614). Elsevier.
Biassoni, R., Di Marco, E., Squillario, M., Barla, A., Piccolo, G., Ugolotti, E., et al. (2020). Gut microbiota in T1DM-onset pediatric patients: Machine-learning algorithms to classify microorganisms as disease linked. The Journal of Clinical Endocrinology & Metabolism, 105(9), e3114–e3126.
Bober, J. R., Beisel, C. L., & Nair, N. U. (2018). Synthetic biology approaches to engineer probiotics and members of the human microbiota for biomedical applications. Annual Review of Biomedical Engineering, 20(1), 277–300.
Article CAS PubMed PubMed Central Google Scholar
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., et al. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3009759
Article PubMed PubMed Central Google Scholar
Buerth, C., Mausberg, A. K., Heininger, M. K., Hartung, H.-P., Kieseier, B. C., & Ernst, J. F. (2016). Oral tolerance induction in experimental autoimmune encephalomyelitis with Candida utilis expressing the immunogenic MOG35-55 peptide. PLoS ONE, 11(5), Article e0155082.
Article PubMed PubMed Central Google Scholar
Charlesworth, C. T., Deshpande, P. S., Dever, D. P., Camarena, J., Lemgart, V. T., Cromer, M. K., et al. (2019). Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nature Medicine, 25(2), 249–254.
Article CAS PubMed PubMed Central Google Scholar
Chasov, V., Zmievskaya, E., Ganeeva, I., Gilyazova, E., Davletshin, D., Filimonova, M., et al. (2024). Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation. Journal of Biomedical Research, 38(6), 531.
Article CAS PubMed PubMed Central Google Scholar
Chen, Y., & Li, L. (2024). The human microbiota and its therapeutic options (pp. 1993–2005). Elsevier.
Cooper, R. M., Wright, J. A., Ng, J. Q., Goyne, J. M., Suzuki, N., Lee, Y. K., et al. (2023). Engineered bacteria detect tumor DNA. Science, 381(6658), 682–686.
Article CAS PubMed PubMed Central Google Scholar
Corrêa, J. D., Calderaro, D. C., Ferreira, G. A., Mendonça, S. M. S., Fernandes, G. R., Xiao, E., et al. (2017). Subgingival microbiota dysbiosis in systemic lupus erythematosus: Association with periodontal status. Microbiome, 5, 1–13.
Crothers, J. W., Chu, N. D., Nguyen, L. T. T., Phillips, M., Collins, C., Fortner, K., et al. (2021). Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: Results of a single-center, prospective, randomized pilot study. BMC Gastroenterology, 21, 1–16.
Dai, Z. F., Ma, X. Y., Yang, R. L., Wang, H. C., Xu, D. D., Yang, J. N., et al. (2021). Intestinal flora alterations in patients with ulcerative colitis and their association with inflammation. Experimental and Therapeutic Medicine, 22(5), 1322.
Article CAS PubMed PubMed Central Google Scholar
Deng, L., Wojciech, L., Gascoigne, N. R., Peng, G., & Tan, K. S. (2021). New insights into the interactions between Blastocystis, the gut microbiota, and host immunity. PLoS Pathogens, 17(2), Article e1009253.
Article CAS PubMed PubMed Central Google Scholar
Derksen, V. F., Allaart, C. F., Van der Helm-Van Mil, A. H., Huizinga, T. W., Toes, R. E., & van der Woude, D. (2023). In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: Implications for the mucosal origin hypothesis. Rheumatology, 62(1), 407–416.
Ding, G., Yang, X., Li, Y., Wang, Y., Du, Y., Wang, M., et al. (2024). Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases. Molecular and Cellular Biochemistry. https://doi.org/10.1007/s11010-024-05077-y
Article PubMed PubMed Central Google Scholar
Esposito, G., Pesce, M., Seguella, L., Lu, J., Corpetti, C., Del Re, A., et al. (2021). Engineered Lactobacillus paracasei producing palmitoylethanolamide (PEA) prevents colitis in mice. International Journal of Molecular Sciences, 22(6), 2945.
Article CAS PubMed PubMed Central Google Scholar
Fenton, T. M., Jørgensen, P. B., Niss, K., Rubin, S. J., Mörbe, U. M., Riis, L. B., et al. (2020). Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in priming of region-specific immunity. Immunity, 52(3), 557-570.e556.
Article CAS PubMed PubMed Central Google Scholar
Fu, Y., Moscoso, D. I., Porter, J., Krishnareddy, S., Abrams, J. A., Seres, D., et al. (2020). Relationship between dietary fiber intake and short-chain fatty acid–producing bacteria during critical illness: A prospective cohort study. Journal of Parenteral and Enteral Nutrition, 44(3), 463–471.
Article CAS PubMed Google Scholar
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., et al. (2018). Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97–103.
Article CAS PubMed Google Scholar
Grondin, J. A., Kwon, Y. H., Far, P. M., Haq, S., & Khan, W. I. (2020). Mucins in intestinal mucosal defense and inflammation: Learning from clinical and experimental studies. Frontiers in Immunology, 11, 2054.
Article CAS PubMed PubMed Central Google Scholar
Guo, J., Cui, G., Huang, W., Zheng, Z., Li, T., Gao, G., et al. (2023). Alterations in the human oral microbiota in systemic lupus erythematosus. Journal of Translational Medicine, 21(1), 95.
Article PubMed PubMed Central Google Scholar
Guo, K., Ye, J., Li, J., Huang, J., & Zhou, Z. (2024). Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large-scale bidirectional Mendelian randomization and external validation study. Diabetes, Obesity and Metabolism, 26(8), 3306–3317.
Article CAS PubMed Google Scholar
Gupta, A., Saha, S., & Khanna, S. (2020). Therapies to modulate gut microbiota: Past, present and future. World Journal of Gastroenterology, 26(8), 777.
Article PubMed PubMed Central Google Scholar
Hamady, Z. Z., Scott, N., Farrar, M. D., Lodge, J. P. A., Holland, K. T., Whitehead, T., et al. (2010). Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut, 59(4), 461–469.
Article CAS PubMed Google Scholar
He, B.-L., Xiong, Y., Hu, T.-G., Zong, M.-H., & Wu, H. (2023). Bifidobacterium spp. as functional foods: A review of current status, challenges, and strategies. Critical Reviews in Food Science and Nutrition, 63(26), 8048–8065.
Comments (0)